Overview
Administration
CU Symbols
GREEN UNIVERSITY
CONTACT
Programs
Admissions
Exchange Student
Academic Units
Life at CU
Academic Services
Medical Services
Quality Assurance Services
Information Services
Creative Space
CU News
3 December 2021
Featured News
November 18, 2021 – Chulalongkorn University held Chula The Impact 5 Seminar on “The Progress on ChulaCov19 — an mRNA vaccine by Thais — the World’s Hope“. Also discussed was the progress of Chula-Baiya, Thailand’s first protein subunit vaccine from tobacco leaves by Baiya Phytofarm Co., Ltd., and Faculty of Pharmaceutical Sciences, Chulalongkorn University. Prof Dr. Bundhit Eua-arporn, Chula President gave the opening remarks and joined the discussion with the panel including Prof. Kiat Ruxrungtham, M.D., Executive Director of the COVID-19 Vaccine Development Project, Chula Vaccine Research Center (CVRC), and Asst. Prof. Dr. Suthira Taychakhoonavudh, Faculty of Pharmaceutical Sciences and CEO & Co-Founder of Baiya Phytofarm Co., Ltd. the developer of the Chula-Baiya vaccine.
Prof. Dr. Kiat said that the clinical trials Phase 1 and 2 of ChulaCov19 are now done. Preliminary results show the volunteers to develop good immunity with only mild to moderate side effects which improved within 1-2 days. The FDA has already given the green light to Phase 3 human trial, which will also be benchmarked against the Pfizer vaccine for efficacy and safety. The trial will start in early 2022 and is expected to be complete in March. Tests in younger volunteers, preparation for mass production in collaboration with Bionet-Asia Co., Ltd., as well as preparation for Gen 2 and 3 vaccines that respond well to mutated strains are also underway. These next generations of vaccines have already been tested in lab animals.
ChulaCov19 vaccine can boost the immune system, and prevent cross-infection in both B Cells and T Cells — twice higher than the Pfizer vaccine. The vaccine design is different from the existing mRNA COVID-19 vaccines to avoid copyright issues, and its encasing is using the latest technology. ChulaCov19 can be stored for 3 months at 2-8 degrees Celsius which is longer than its counterparts. With a 2.3-billion-baht budget, mass production of the vaccine is estimated to be in June-September 2022 after the FDA approval.
On the progress of Chula-Baiya Vaccine, Asst. Prof. Dr. Suthira said that this protein subunit vaccine from N. benthamiana tobacco leaves uses a recombinant protein production with genetically-altered pathogenic bacteria in tobacco leaves. Currently, the industrial-grade vaccine factory, with a monthly capacity of 1-5 million doses is complete. Phase 1 clinical trials started on September 27 and no worrisome side effects have been found in volunteers, but the efficacy and safety of the vaccine are pending the data. Phase 2 trial is underway. Meanwhile, a second-generation vaccine is being developed from more than 10 strains of mutated viruses to combine into a cocktail vaccine. Phase 1 clinical trial on volunteers is expected in January 2022. The best vaccine will be selected for Phase 2 trials in February. Chula-Baiya vaccine can be approved for use in the 3rd or 4th quarter of 2022.
Prof. Dr. Jintavee Khlaisang, Faculty of Education, Chulalongkorn University, Named National Outstanding Researcher 2023 for Educational Technology Innovation to Support Digital Learning
Assoc. Prof. Dr. Wirote Aroonmanakun from the Faculty of Arts, Chulalongkorn University, an Expert in Thai Corpus and Language Processing, Awarded the 2023 National Outstanding Researcher Award in Philosophy
Chulalongkorn University Holds the “Chula Health Care Body & Mind” Fest
International Seminar: Health Equity, Civic Engagement, Social Innovation
March 16, 2023 from 9:00-11:30 A.M.
Dipak C. Jain Hall, Sasa International House, Chulalongkorn University
Chula Awarded “4-Star Healthy University”
Prof. Dr. Patcha U-Tiswannakul, Faculty of Fine and Applied Arts, Chulalongkorn University, National Outstanding Researcher in Philosophy 2023, Researches Transdisciplinary Innovation in Sustainable Fashion and Textile Design
Chula produces able graduates who become quality citizens for society. Prof. Bundhit Eua-arporn President of Chulalongkorn University
Chula produces able graduates who become quality citizens for society.
Prof. Bundhit Eua-arporn President of Chulalongkorn University
This website uses cookies to personalize content, provide the best user experience, and improve Chula website services.
ท่านสามารถเลือกการตั้งค่าคุกกี้โดยเปิด/ปิด คุกกี้ในแต่ละประเภทได้ตามความต้องการ ยกเว้น คุกกี้ที่จำเป็น
ประเภทของคุกกี้ที่มีความจำเป็นสำหรับการทำงานของเว็บไซต์ เพื่อให้คุณสามารถใช้เว็บไซต์ได้อย่างเป็นปกติ ท่านไม่สามารถปิดการทำงานของคุกกี้นี้ในระบบเว็บไซต์ของเราได้
คุกกี้ประเภทนี้จะทำการเก็บข้อมูลพฤติกรรมการใช้งานเว็บไซต์ของคุณ โดยมีจุดประสงค์คือนำข้อมูลมาวิเคราะห์เพื่อปรับปรุงและพัฒนาเว็บไซต์ให้มีคุณภาพ และสร้างประสบการณ์ที่ดีกับผู้ใช้งาน เพื่อให้เกิดประโยชน์สูงสุด หากท่านไม่ยินยอมให้เราใช้คุกกี้นี้ เราอาจไม่สามารถวัดผลเพื่อการปรับปรุงและพัฒนาเว็บไซต์ให้ดีขึ้นได้ Cookies Details